Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
2.840
-0.020 (-0.70%)
At close: Jun 23, 2026, 4:00 PM EDT
2.820
-0.020 (-0.70%)
Pre-market: Jun 24, 2026, 6:04 AM EDT
Equillium Market Cap
Equillium has a market cap or net worth of $179.56 million as of June 24, 2026. Its market cap has increased by 1,222.91% in one year.
Market Cap
179.56M
Enterprise Value
118.93M
1-Year Change
1,222.91%
Ranking
Category
Stock Price
$2.84
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $179.56M, a decrease of -23.44%. That is a compound annual growth rate of -3.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 179.56M | 90.25% |
| Dec 31, 2025 | 94.38M | 256.04% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovaBridge Biosciences | 186.19M |
| MediWound | 181.47M |
| YD Bio | 181.43M |
| LENZ Therapeutics | 180.29M |
| Precision BioSciences | 180.10M |
| Innate Pharma | 179.43M |
| AN2 Therapeutics | 179.36M |
| Turn Therapeutics | 178.43M |